Du är här


Rapid Micro Biosystems: Rapid Micro Biosystems Announces the Commercial Availability of the Growth Direct(TM) MultiTest System

New System Supports Testing of Key Applications in a Single Instrument
LOWELL, Mass., Sept. 01, 2015 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, the
provider of automated, rapid, non-destructive detection and enumeration
technologies in microbiology, today announced the continued expansion of the
Growth Direct(TM) product line with the launch of the Growth Direct MultiTest
System. The technology automates the incubation, detection, and results
reporting steps for bioburden, environmental monitoring and sterility testing
-- within a single instrument. The proven method is based on the detection
of the natural auto-fluorescence of microorganisms, and can detect growing
colonies in about half the time of the traditional tests, providing time and
resource savings.

The MultiTest System expands the existing Growth Direct(TM) technology
platform currently used in FDA regulated manufacturing facilities.

* Rapid Results: Positive results are available starting within hours with a
final result in half the time of the traditional test.
* Sample Preparation Unchanged: Microbiologists prepare samples using
identical steps to the traditional methods.
* Non-Destructive: No additional reagents are added. Samples with positive
results can continue to grow and are available for additional ID testing.
* Automation: Incubation, detection, and results reporting are managed by the
Growth Direct(TM) MultiTest System, reducing manual errors, and freeing
resources to work on higher value tasks.
* Complete Audit Trail: A complete history of user activity as well as sample
processing are available, ensuring compliance with 21 CFR Part 11.

"Companies have been looking for a way to increase their efficiency, reduce
errors and deliver results more quickly across the portfolio of tests they
conduct," states Julie Sperry, Chief Commercial Officer. "The Growth Direct
MultiTest is unique in its ability to run all the applications concurrently
on the same system."

"Using a single, automated, self-contained microbial QC testing system changes
the way that businesses view rapid methods for their quality control labs,"
said Robert Spignesi, President and CEO of Rapid Micro Biosystems. "Companies
now have the option to perform all their key tests on a single platform
versus the inefficiencies in validation, training and maintenance of
deploying unique solutions for each application. This allows QC labs to see
the benefits while minimizing their up-front investment."

Rapid Micro Biosystems is hosting hands-on workshops with the Growth
Direct(TM) System in both the US and Europe. To register for a workshop,
visit http://www.rapidmicrobio.com/workshops.

About Rapid Micro Biosystems

Rapid Micro Biosystems delivers the Growth Direct(TM) System, an automated,
non-destructive rapid detection and enumeration technology based on the
compendial method for microbial quality control in pharmaceutical
manufacturing. The system automates and accelerates detection and
enumeration in the areas of sterility testing, environmental monitoring, and
bioburden testing, eliminating manual steps and analysis. The detection
technology, first developed and patented by Dr. Don Straus, Ph.D., uses the
natural auto-fluorescence of microbes and requires no reagents. For more
information about Rapid Micro Biosystems visit
Mark Severns

Rapid Micro Biosystems


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Rapid Micro Biosystems via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.